• No results found

C-reactive protein and risk of venous thromboembolism: Results from a population-based case-crossover study

N/A
N/A
Protected

Academic year: 2022

Share "C-reactive protein and risk of venous thromboembolism: Results from a population-based case-crossover study"

Copied!
6
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Our findings suggest that hematocrit and related hematologic variables such as hemoglo- bin and red blood cell count are risk factors for venous thromboembolism in a general

High-sensitivity C-reactive protein is associated with risk of arterial cardiovascular disease but conflicting results have been reported on its role in venous thromboembolic

In the present study, we found that the risk of VTE increased with 11% per one day increase in total days spent in hospital during the 90-day hazard period, and the risk was

Hyperglycemia, Assessed by HbA1c, and Future Risk of Venous Thromboembolism -The Tromsø Study1. Running head: HbA1c

Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study.. Journal of thrombosis and haemostasis

Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Grimnes G, Horvei LD, Tichelaar V, Braekkan SK, Hansen

The aim of this thesis was to investigate the relation between coffee consumption, emotional states, cigarette smoking and socioeconomic status and future risk of incident VTE in

Concomitant presence of transient risk factors for VTE (e.g. infections, immobilization, major surgery, central venous catheter etc.) following an MI could result in a short